To test associations between subclinical brain infarcts (SBIs) and functional decline independently of intervening clinical vascular events and other vascular risk factors. DESIGN: Longitudinal follow-up for a mean 7.3 years. Generalized estimating equation models were used to test associations between SBIs, number of perivascular spaces (PVSs), baseline Barthel Index (BI), and change in BI, adjusting for sociodemographic, vascular, and cognitive risk factors and for stroke and myocardial infarction occurring during follow-up. SETTING: Population-based prospective cohort study. PARTICIPANTS: Stroke-free individuals from the racially and ethnically diverse Northern Manhattan Study (N=1,290). MEASUREMENTS: Annual functional assessments using the BI (range 0-100). RESULTS: Mean age was 70.6 ± 9.0, 40% of participants were male, 66% were Hispanic, 193 (16%) had SBIs, and 508 (42%) had large PVSs. SBIs were not associated with baseline BI. In a fully adjusted model, there was a change in BI of -0.85 points per year (95% confidence interval (CI)=-1.01 to -0.69); those with SBI had an additional change in BI 0f -0.88 points (95% CI=-1.43 to -0.32). There were no associations between PVS and baseline BI or change in BI. CONCLUSION: In a large population-based study, we found a strong and independent association between "subclinical" markers of cerebrovascular injury and important clinical, person-centered functional trajectories. Future research could clarify the evolution of such subclinical markers over time and test strategies to prevent their progression and minimize related disability. J Am Geriatr Soc 66:2144-2150, 2018.
S ubclinical brain infarcts (SBIs) are at least 5 times as prevalent as clinical strokes. 1 Vascular risk factors are associated with incident SBIs. 2 SBIs have been associated with greater risk of stroke, mortality, [3] [4] [5] cognitive impairment, and loss of function. [6] [7] [8] The pathophysiology of SBIs is debated, and it is unclear whether their effect is similar to those of other pathological brain findings such as perivascular spaces (PVSs). 9 Also, there is little information regarding the time course of change in function in relation to SBIs and the specific aspects of function that SBIs compromise.
We hypothesized that SBI would be found to be independently associated with worse baseline functional status and steeper slope of change in individuals free of stroke at baseline but that measures of perivascular spaces (PVS) would not.
METHODS
The Northern Manhattan Study (NOMAS) magnetic resonance imaging (MRI) study included 1,290 individuals aged 50 and older without MRI contraindications or clinical stroke who were able to provide signed informed consent. Imaging was performed using 1.5-T MRI (Philips Medical Systems, Best, Netherlands), including axial T1, axial T2, axial proton density, dual-spin echo, diffusion weighted imaging, and fluid attenuation inversion recovery (FLAIR) sequences. Institutional review boards at Columbia University and the University of Miami approved this study.
Baseline Evaluation
Bilingual research assistants interviewed participants and collected data using standardized questions asking about hypertension, diabetes mellitus, hypercholesterolemia, cigarette smoking, alcohol use, and cardiac conditions. 10 A thorough baseline examination including a comprehensive medical history, physical examination, review of medical records, quality of life (QOL) assessed using the Spitzer QOL index, and fasting blood samples was conducted.
Follow-Up
Participants were followed annually using telephone screening to detect change in vital status, new neurological or cardiac symptoms and events, interval hospitalizations, cognitive function, and functional status using the Barthel Index (BI). Only 2 subjects were lost to follow-up after their baseline examinations, and the average annual contact rate was 99%.
A positive screen for any potential cardiac or neurological event was followed by an in-person assessment to determine whether a vascular outcome had occurred and a review of medical records from relevant hospitalizations. All admissions and discharges of NOMAS participants at Columbia University Medical Center-where approximately 70% of hospitalized vascular events occur-were screened for possible outcome events. Hospital records were reviewed to classify outcomes as previously reported.
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Stroke included ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage, and 3 or more stroke neurologists classified all stroke cases. MI was defined according to criteria adapted from 2 trials 12,13 and adjudicated by cardiologists. As of the end of 2014, 53 first definite and probable MIs and 64 first strokes (59 infarcts, 3 intracerebral hemorrhages, 2 subarachnoid hemorrhages) had occurred during follow-up.
Study Outcome
The BI 14, 15 measures performance in 10 activities of daily living (ADLs) and has a score that ranges from 0 to 100 in 5-point increments, with 100 indicating normal physical functioning. Telephone assessments using the BI are reliable. 16 Although it is an ordinal scale, recent research has advocated analyzing the scale as a continuous variable because that gives it greater power to detect associations, ability to describe the course of change over time in linear form, and avoidance of potential misclassification due to crude categorization.
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Explanatory Variables
We defined SBI in two ways: (1) brain MRI lesions more than 3 mm in diameter and with an intensity similar to that of cerebrospinal fluid. SBI location was classified as cortical or subcortical. This definition of SBI was used for consistency with earlier definitions in previous publications.
(2) Pathology-informed SBI (pSBI) represented a re-reading of the original MRI scans and were informed by pathological understanding of the stroke mechanism as follows: lacunar infarcts were in penetrating artery territories, subcortical but probable embolic infarcts were in medullary artery territories, cortical infarcts were probably embolic, and cerebellar infarcts were located in the cerebellum. The appearance of the rim of lesions on FLAIR was used to identify infarcts. SBI location was coded as cortical or subcortical.
Small PVSs (SPVSs) and large PVSs (LPVSs) were identified in 1,228 participants according to modified criteria as previously described. 20 In brief, SPVSs were parenchymal T1 hypointensities less than 3 mm in effective axial diameter without associated FLAIR hyperintensity, and number of SPVSs was categorized according to brain region as 0 (none), 1 (1-3 voids), 2 (≥4 voids) in each of 12 anatomical brain regions. Total SPVS score was a sum of scores across all brain regions. Lesions greater than 3 mm in effective diameter were characterized as LPVSs or SBIs according to previously described criteria. 20 Briefly, we used the FLAIR rim as the strongest determinant of infarction. For lesions in the brain stem and the upper basal ganglia, we tolerated a fainter FLAIR signal to identify infarct than in the STandards for ReportIng Vascular changes on nEuroimaging (STRIVE) criteria and previous studies. Two vascular neurologists (JG, MSE) who rated each void separately and had agreement of greater than 95% determined the location of pSBI by consensus. 20 An operator traced dura mater, and nonbrain structures were manually removed from images. Pixel-intensity histograms for cerebral spinal fluid (CSF) and brain white and gray matter were modeled. Semi-automated measurements of pixel distributions were made to identify the optimal pixel-intensity threshold to distinguish CSF from brain matter. Total cranial volume (TCV) constituted the sum of whole brain volume voxels from the T1 segmentation process. White matter hyperintensity volume (WMHV) was calculated as the sum of voxels 3.5 standard deviations or more above mean image intensity multiplied by pixel dimensions and section thickness and divided by TCV. 21 
Covariates
Analytical models were adjusted for demographic characteristics (age, sex, race, ethnicity), medical risk factors (body mass index, hypercholesterolemia (according to self-report, lipid-lowering therapy use, or fasting total cholesterol level >240 mg/dL), diabetes mellitus (according to self-report, fasting blood glucose level >126 mg/dL, or insulin or oral hypoglycemic use), hypertension (systolic blood pressure (BP) > 140 mmHg or diastolic BP >90 mmHg based on average of 2 BP measurements or self-report of hypertension or antihypertensive use)), smoking (nonsmoker vs smoker within past year), alcohol use (with moderate alcohol use classified as 1 drink/month to 2 drinks/day), any physical activity (vs none), social variables (marital status, insurance status (uninsured or Medicaid vs Medicare or private insurance], number of friends (individuals participant knows well enough to visit in their homes), years living in community), and cognitive and mood factors (depressed mood, performance on Mini-Mental State Examination (analyzed as continuous variable), and Spitzer quality of life (QOL) index score).
Statistical Analysis
We analyzed associations between SBI and baseline BI and slope of decline over time. We first calculated the distributions of SBI, pSBI, pSBI subtype (penetrating artery, medullary artery, embolic cortical, cerebellar), SPVS, LPVS, baseline covariates, and BI.
Because of correlations between repeated measures of BI in each individual, regression models using generalized estimating equations (GEEs) with an identity link function were used to assess the association between primary predictors (SBI, SPVS, LPVS, pSBI, penetrating artery pSBI, SBI location) and repeated measurements of BI, adjusting sequentially for baseline demographic variables, medical risk factors, smoking, alcohol use, physical activity, social variables, and cognitive/mood factors, as defined above. Each primary predictor was tested in a separate model.
To assess whether MRI variables were associated with change in outcomes over time, we included interaction terms between time of follow-up assessment and the main predictor variable. For each model, there were 3 main estimates of interest: annual change in BI, additional annual change in the presence of the predictor of interest (e.g., SBI), and baseline difference in BI in the presence of the predictor of interest. Various model diagnostics including tests of linearity, residual plots, and goodness-of-fit measures were used to evaluate the final model. There was no evidence to suggest lack of linearity in the final models. As a working correlation structure for the GEE models, we chose the exchangeable (intraclass) structure and compared the quasi-likelihood under the independence model criterion obtained with this model with one using the unstructured working correlation structure. To assess whether interval vascular events such as clinical stroke and MI were implicated in the trajectory of functional status, we ran a second set of models in which stroke and MI were included as time-varying covariates. We tested whether the relationship between SBI and functional status remained after adjusting for these events. We also tested whether the relationship between SBI and functional trajectories remained after adjusting for WMHV.
A sensitivity analysis was performed in participants with a BI of 95 or 100 at baseline (the closest BI measurement to the MRI date). The association between SBI location (cortical, subcortical, both) and trajectories of functional status was examined using a multilevel categorical location variable. Table 1 shows distributions of baseline variables stratified according to presence of SBI; those with SBI were older, more likely to be male, and more likely to have hypertension. One thousand one hundred thirty-six (88.8%) had a BI of 95 or 100 at baseline. Mean baseline BI was 96.5 ± 8.3. One hundred ninety-three participants (15.6%) had SBIs, 246 (19.1%) had pSBIs, 508 (42.1%) had 1 or more LPVSs, and 193 (16.0%) had a total PVS score of 4 (range 0-22). In those with no LPVSs (n=695), mean WMHV was -0.028 ± 0.985, and 62 (8.9%) had SBIs; in those with 1 or more LPVSs, mean WMHV was -0.021 ± 0.948, and 123 (24.2%) had SBIs. Eighty-three (6.7%) had cortical SBIs, 88 (7.1%) had subcortical SBIs, and 22 (1.8%) had both. Thrity-nine (3.0%) had cerebellar pSBIs, 37 (2.9%) had cortical pSBIs, 143 (11.1%) had pSBI in the territory of the medullary arteries, and 85 (6.6%) had pSBIs in the territory of penetrating arteries. Mean follow-up was 7.3 ± 2.1 years.
RESULTS
SBIs were not associated with baseline functional status but were strongly and consistently associated with rapid decline in function over time. The magnitude of the association between SBIs and rate of change varied between the unadjusted model (-1.10 BI points per year, 95% CI=-1.64 to -0.56 points per year) and the fully adjusted model (-0.88 BI points per year, 95% CI=-1.43 to -0.32 points per year) (Figure 1) . The magnitude and significance of this association did not vary substantially when WMHV was added to the models (Supplementary Table S1 ). There was a similar association between SBIs and the mobility and nonmobility domains of the BI (Supplementary Table S2) proportional to the portion of the BI comprising each domain.
Examining pSBIs, results were similar ( Figure 2) , with -1.02 additional BI points per year (95% CI=-1.52 to -0.51 points per year) with pSBIs in an unadjusted model and-0.89 additional points per year (95% CI=-1.43 to -0.36 points per year) in a fully adjusted model. Results were similar when the number of pSBIs was tested, with an additional change of -0.40 points per year (95% CI=-0.72 to -0.08) with each additional pSBI in a fully adjusted model. There was a similar association between pSBIs and the mobility and nonmobility domains of the BI, proportional to the portion of the BI comprising each domain:-0.34 points per year (95% CI=-0.56 to -0.13 points per year) for mobility domains and -0.54 (95% CI=-0.89 to -0.19 points per year) for nonmobility domains.
There was a significant and consistent association between presence of penetrating artery infarcts and rapid decline in functional status over time, with a change of-1.39 additional BI points per year (95% CI=-2.23 to -0.55 points per year) with penetrating artery infarcts in an unadjusted model and -1.24 points per year (95% CI=-2.11 to -0.37 points per year) in a fully adjusted model.
In contrast to findings for SBIs and pSBIs, there were no significant associations between LPVSs and baseline BI or change in BI over time in unadjusted or adjusted models with a dichotomous definition of LPVS or one that incorporated the number of LPVSs per individual. Similarly, when the SPVS score was tested, there were no significant associations with baseline BI score or change in BI over time in unadjusted or adjusted models or when mobility and nonmobility domains of the BI were tested separately (results not shown).
Sensitivity analysis was performed in participants with a baseline BI of 95 or 100 (n=1,136). Although the magnitudes of overall decline and of additional decline with MRI variables were both slightly reduced in most models, there were still highly significant associations paralleling the findings in models in the entire cohort. For example, in those with a baseline BI of 95 or 100, SBIs were associated with an additional change of -0.79 points per year (95% CI=-1.34 to -0.24 points per year). Table 2 shows models testing the association between SBI location and functional status. When tested in separate models, cortical (-0.79 points per year, 95% CI=-1.63-0.06 points per year) and subcortical location (-1.11 points per year, 95% CI=-1.81 to -0.41 points per year) were associated with rapid decline in functional status over time but not with baseline BI score. When tested in the same model, subcortical location was associated with rapid decline over time (-0.90 additional BI points per year, 95% CI=-1.60 to -0.20 points per year) but not cortical location (-0.49 points per year, 95% CI=-1.36-0.38 points per year), and neither was associated with baseline BI score. Individuals with cortical and subcortical SBIs had more than double additional decline in functional status than those with subcortical SBIs alone (-2.68 points per year, 95% CI=-5.03 to -0.32 points per year). Cortical (-0.95 points per year, 95% CI=-1.72 to -0.17 points per year) and subcortical (-1.35, 95% CI=-2.37 to -0.33 points per year) pSBIs were individually associated with rapid decline in functional status over time, and there was a trend for an association of similar magnitude with cortical and subcortical pSBIs (-1.23 points per year, 95% CI=-2.63-0.17 points per year).
DISCUSSION
In this large population-based MRI study with mean follow-up of 7 years, we found a strong, consistent, independent association between SBI and rapid decline in function over time in addition to the annual decline in function associated with age. Despite healthy risk factor profiles and good functional status, 19.1% of the cohort had SBIs on imaging using a classification system informed by characteristics found in pathology studies. 20 The presence of SBIs doubled the annual decline in functional status due to aging. Hence, whereas an individual may be expected to lose the ability to perform 1 ADL every 5 years due to aging, the presence of SBIs was associated with the loss the ability to perform of 2 ADLs every 5 years. Functional decline was seen with SBI using mobility and nonmobility domains of the BI as separate outcomes. This pattern of association was seen with MRI imaging markers believed to be caused by ischemic damage (SBIs and lacunar infarcts) but not with other MRI structural findings such as SPVSs and LPVSs, which are believed to represent less structural damage to the brain parenchyma. Additional adjustment for WMHV did not affect associations. There was a greater decline in functional status with increasing number of SBI and lacunar SBI, reflecting a doseresponse relationship that lends biological plausibility to the association. These associations were seen even in those with no baseline disability (BI of 95 or 100), which emphasizes the "subclinical" nature of these predictors and yet their strong predictive power for downward functional trajectories. These findings support the concept of "vascular functional impairment," whereby subclinical lesions presumed to be caused by vascular dysfunction have an independent association with functional impairment and decline. 22 We found evidence of a relationship between SBI location and accelerated functional decline over time. Using the original classification of SBI, subcortical location was associated with accelerated decline over time, and having cortical and subcortical SBIs together was associated with the most decline. It is likely that having SBIs in both locations indicates a greater overall or cumulative burden of subclinical ischemic lesions, which has a greater effect on ongoing functional decline. Using the pathology-informed classification system, the magnitude of additional decline over time with cortical and subcortical SBIs was similar, and presence of SBI in both locations was not associated with any incremental decline over time. The differences between SBIs and pSBIs may reflect more sensitive discrimination between infarct and PVS with the revised pSBI readings, but more research is needed to clarify these differences.
SBIs have been associated with vascular events, cognitive impairment, 23 and poor functional status. 6 Asymptomatic brain MRI abnormalities, including WMH and infarcts, have been associated with functional impairment over up to 4 years of follow-up. 6, 8, 24 In 267 men aged 74 95, 25 those with white matter lesions at baseline had twice the odds of having a 1-standard deviation drop in cognitive performance at 5 years; 2,450 individuals were followed for a mean of 4 years, and WMHV and brain infarcts were associated with higher incidence of disability and more rapid decline in gait speed. 6 Adjustment for incident stroke, dementia, and Mini-Mental State Examination score did not attenuate associations. Unlike these prior studies examining relationships between SBI and cognition and functional status, we estimated associations with baseline functional status and change over time using multiple repeated measures and adjusted for occurrence of stroke and MI, ensuring that associations were independent of clinical events. One novel finding was that SBIs were associated not with baseline BI but with accelerated decline over time.
We found no significant associations between PVSs and functional status. The underlying mechanism(s) of which perivascular spaces may be a marker are not well understood at this time. Although some studies have shown associations between PVSs and vascular risk factors and outcomes, [26] [27] [28] the mechanisms underlying PVSs may involve neurodegenerative processes [29] [30] [31] that may have a different effect on functional trajectories than cerebrovascular processes.
There are several brain structural changes associated with cerebrovascular disease that may affect cognition and functional status. For example, brain infarcts have been associated with smaller hippocampal volumes; 32 low gray matter volume; 33 declines in gait speed, cadence of gait, and length of steps; [34] [35] [36] and gait variability, all of which can affect cognition and mobility. 37 Subcortical SBIs and WMHs are in many cases manifestations of small vessel damage, and they often overlap. Another possible mechanism for steeper functional decline over time is the accumulation of SBIs, which we were not able to assess with 1 MRI per individual.
Strengths of this study include the large population-based cohort, accurate assessment of events during follow-up, minimal loss to follow-up, state-of-the-art imaging and measurement of subclinical brain vascular disease, and repeated measures of functional outcomes that allowed trajectory analysis. With reliable surveillance and tracking of events and regular and repeated measurements of functional status, this research highlights the central role that "subclinical" disease probably plays in functional ability and health over time. One limitation of the study is that we slightly modified the STRIVE criteria for reading of PVSs, which we intended to better discriminate PVS from infarcts, but this may preclude direct comparison with other studies with differing methods.
Better imaging might facilitate the design of studies to better evaluate relationships between SBIs and functional .08 Difference in BI with subcortical pSBI location .09
Models also adjusted for age at the time of magnetic resonance imaging, sex, race, ethnicity, diabetes, hypertension, coronary artery disease, hypercholesterolemia, physical activity, alcohol use, smoking, body mass index, marital status, insurance status, number of friends, Mini-Mental State Examination score, and stroke and myocardial infarction occurring during follow-up. 1 Versus no SBI in this location. 2 Versus no SBI. Author Contributions: MSD, CBW: study concept and design, analysis and interpretation of data, preparation of manuscript. YKC, YPM: analysis and interpretation of data, preparation of manuscript. JTD: acquisition of subjects and data, preparation of manuscript. JG: acquisition of data, analysis and interpretation of data, preparation of manuscript. RLS, MSE: study concept and design, acquisition of subjects and data, preparation of manuscript.
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